OUTER RETINAL TUBULATION IN BIETTI CRYSTALLINE DYSTROPHY ASSOCIATED WITH THE RETINAL PIGMENT EPITHELIUM ATROPHY

Retina. 2023 Apr 1;43(4):659-669. doi: 10.1097/IAE.0000000000003697. Epub 2022 Dec 14.

Abstract

Purpose: To determine the prognostic value of outer retinal tubulation (ORT) in the eyes of a Chinese cohort with Bietti crystalline dystrophy (BCD).

Methods: This retrospective, multicenter cohort study enrolled 42 patients with clinically and genetically diagnosed BCD. Eighty eyes with good-quality images of spectral domain optical coherence tomography were included. Demographic details and clinical data were collected. The characteristics of ORT, including prevalence, location, and morphologic characteristics were analyzed.

Results: Forty-two patients with BCD harbored potentially CYP4V2 disease-causing mutations. The mutation spectrum comprised 17 unique variants, 9 of which were novel. Fifty-two of these 80 eyes demonstrated evidence of ORT. The incidence of ORT is significantly higher in Stage 2 than other stages ( P < 0.001). ORT was mainly bilateral and located at the margin of the atrophic area of retinal pigment epithelium (RPE), and dynamically changed with the progressive RPE atrophy. The process of RPE atrophy was slower in eyes with ORT ( P = 0.017), with significantly longer intact RPE width in Stage 3 ( P = 0.024). Eyes with ORT had slower vision loss than eyes without ORT ( P = 0.044).

Conclusion: ORT may be a sign of the onset of RPE atrophy in early-stage BCD and may suggest less risk of rapid progression in late-stage BCD.

Trial registration: ClinicalTrials.gov NCT00369116.

Publication types

  • Multicenter Study

MeSH terms

  • Atrophy / pathology
  • Cohort Studies
  • Humans
  • Retinal Degeneration* / pathology
  • Retinal Diseases* / diagnosis
  • Retinal Diseases* / genetics
  • Retinal Diseases* / pathology
  • Retinal Pigment Epithelium / pathology
  • Retrospective Studies
  • Tomography, Optical Coherence

Supplementary concepts

  • Bietti Crystalline Dystrophy

Associated data

  • ClinicalTrials.gov/NCT00369116